Details for Patent: 12,144,873
✉ Email this page to a colleague
Which drugs does patent 12,144,873 protect, and when does it expire?
Patent 12,144,873 protects LUTATHERA and is included in one NDA.
Protection for LUTATHERA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has one hundred and thirty patent family members in twenty-five countries.
Summary for Patent: 12,144,873
| Title: | Stable, concentrated radionuclide complex solutions |
| Abstract: | The present invention relates to radionuclide complex solutions of high concentration and of high chemical stability, that allows their use as drug product for diagnostic and/or therapeutic purposes. The stability of the drug product is achieved by at least one stabilizer against radiolytic degradation. The use of two stabilizers introduced during the manufacturing process at different stages was found to be of particular advantage. |
| Inventor(s): | Donato Barbato, Clementina Brambati, Daniela Chicco, Francesco de Palo, Lorenza Fugazza, Maurizio Mariani, Giovanni Tesoriere |
| Assignee: | Advanced Accelerator Applications SA |
| Application Number: | US18/640,891 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 12,144,873 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 12,144,873
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aaa Usa Inc | LUTATHERA | lutetium lu 177 dotatate | SOLUTION;INTRAVENOUS | 208700-001 | Jan 26, 2018 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,144,873
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 119655 | ⤷ Start Trial | |||
| Australia | 2018433575 | ⤷ Start Trial | |||
| Australia | 2022203683 | ⤷ Start Trial | |||
| Australia | 2024201217 | ⤷ Start Trial | |||
| Australia | 2025202231 | ⤷ Start Trial | |||
| Australia | 2025204901 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
